Supernus Announces Second Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Supernus Pharma (SUPN) Misses Q2 EPS
August 8, 2023 4:36 PM EDTSupernus Pharma (NASDAQ: SUPN) reported Q2 GAAP EPS of ($0.02), which may not compare to the analyst estimate of $0.22. Revenue for the quarter came in at $135.56 million versus the consensus estimate of $144.53 million.
For earnings history and earnings-related data on Supernus Pharma (SUPN) click here.
... More